TopicsPOSITIVE

Korea Aerospace Industries Q1 2026 Revenue Hits $7.5B, Up 56% YoY

Korea Aerospace Industries (KAI) reported Q1 2026 revenue of $7.5B and operating profit of $463M, representing 56% and 43% year-over-year growth respectively. Brokerages upgraded price targets, citing a turnaround in earnings and expansion across all business divisions.

전영빈·May 7, 2026 at 16:01·2 min read

한국어로도 볼 수 있습니다한국어로 보기 →

kai-q1-2026-revenue-7-5b-56-percent-growth

AIKey Summary

KAI's Q1 2026 revenue jumped to $7.5B, up 56% year-over-year, with operating profit rising 43% to $463M
Quarter-over-quarter declines reflect delivery timing, but strong YoY growth signals a sustained business turnaround

LIVEKorea Aerospace Industries047810

₩171,800-2.72%

Updated May 7, 04:50 PM

Korea Aerospace Industries (KAI) announced Q1 2026 revenue of $7.5B, surging 56.3% year-over-year, according to preliminary DART filings released May 7, 2026.

Q1 2026 Results at a Glance

Both revenue and operating profit posted double-digit year-over-year gains. However, compared to the prior quarter (Q4 2025), revenue and operating profit declined 25.5% and 12.8% respectively.

Revenue: $7.5B, +56.3% YoY / -25.5% QoQ
Operating profit: $463M, +43.4% YoY / -12.8% QoQ
Net income: $285M, +41.4% YoY / -33.5% QoQ
Operating margin: ~6.1%

Market Reaction

Stock price rose 6% following the earnings release. DB Securities and Hana Securities both raised price targets, citing "all business segments entering growth phase." Analysts attributed strength to near-term revenue expectations from KF-21 fighter jet production ramp and Saudi space ventures.

This article was auto-generated based on DART official filings and international/domestic media reports, with the aim of rapidly disseminating key data immediately after announcement. Investors are advised to review official company filings before making trading decisions.

047810

Related Assets

전영빈

Topics

KR Stocks

IMGT Invests $500K in US Subsidiary for FDA Clinical Trial Management

IMGT (456570) announced on May 7, 2026 via DART that it will invest $500,000 (approximately $344K USD equivalent) in IMGT USA, Inc., its 100% subsidiary based in Virginia, to manage FDA-regulated clinical trials and establish direct product distribution and sales channels in the US market.

456570

LG Q1 2026 Operating Profit Falls 35% YoY to $285M

LG (003550) reported Q1 2026 consolidated operating profit of 413.8 billion won ($285 million), down 35.1% year-over-year despite returning to profitability from the previous quarter's loss. Revenue declined 7% to 1.8 trillion won ($1.24 billion).

003550

KT&G Q1 2026 Operating Profit $251M, Up 27.7% YoY

KT&G reported consolidated Q1 2026 operating profit of $251 million, a 27.7% increase year-over-year. Revenue also grew 14.3% to $1.18 billion during the same period.